#11371. Tobacco and COVID-19: Understanding the science and policy implications

October 2026publication date
Proposal available till 11-07-2025
4 total number of authors per manuscript0 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Health (social science);
Public Health, Environmental and Occupational Health;
Medicine (miscellaneous);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
2350 $1200 $1050 $900 $
Contract №11371.1 Contract №11371.2 Contract №11371.3 Contract №11371.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

More details about the manuscript: Science Citation Index Expanded or/and Social Sciences Citation Index
Abstract:
There is an urgency to understand the relationship between COVID-19 and tobacco use. Smokers with diseases where tobacco is a major causative factor, e.g. COPD, ischaemic heart disease, cancers and diabetes were all quickly recognized as significant risks for poor prognosis in COVID-19. The effect of smoking itself may be more nuanced. The relationship between SARS-CoV-2 and ACE-2 has also led to a number of studies exploring the possible mechanism of the relationship between smoking and ACE-2 (Angiotensin Converting Enzyme 2), but again it is not clear-cut. Not only that, but it seemed likely that the tobacco industry would take the opportunity to further its commercial aims amid the current uncertainty and distress and the neglect of Tobacco Control caused by the health emergency.
Keywords:
ACE-2; COVID-19; Smoking; Tobacco control; Tobacco sales ban

Contacts :
0